8156 — Sinopharm Tech Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- HK$205.95m
- HK$344.60m
- HK$61.25m
- 15
- 21
- 79
- 28
Annual cashflow statement for Sinopharm Tech Holdings, fiscal year end - June 30th, HKD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -111 | -94.2 | -11.4 | -20.3 | -1.08 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 76.8 | 64.4 | 93.1 | 13.7 | 2.67 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 17.6 | -9.46 | -78.9 | -4 | -8.62 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.21 | -36.8 | 4.73 | -9.25 | -5.7 |
| Capital Expenditures | -10.1 | -0.121 | 0 | -3.33 | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 5.07 | 0.036 | 0.002 | -1.53 | -0.006 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.05 | -0.085 | 0.002 | -4.86 | -0.006 |
| Financing Cash Flow Items | 20.6 | -2.48 | 0 | -0.023 | -1.51 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 12.5 | 32.2 | -4.52 | 15 | 9.98 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.736 | -4.49 | -1.22 | 0.864 | 4.31 |